Letter to Sanofi calling for patent withdrawals on critical TB drugs

TAG and OTMeds call on Sanofi to reverse its efforts to patent two obvious combinations of two critical drugs to prevent TB: rifapentine and isoniazid.

Read More →

TAG launches two new TB Activist Guides

Treatment Action Group launches two new TB Activist Guides: An Activist’s Guide to Tuberculosis Diagnostic Tools, and An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis.

Read More →

Activating a human rights-based TB response

A technical brief for policymakers and program implementers - a joint effort of the Global Coalition of TB Activists, the Stop TB Partnership and the Northwestern Pritzker School of Law.

Read More →

TB CAB Statement

TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction

Read More →

Treatment Action Group statement on bedaquiline unaffordability

Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.

Read More →

Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment

120,707 people signed petitions urging the corporation to drop the price.

Read More →

Stop TB Partnership and Johnson & Johnson announce price reduction for bedaquiline

Stop TB Partnership and Johnson & Johnson, with support from USAID and the Global Fund, announce price reduction for bedaquiline for treatment of drug-resistant TB in low- and middle-income countries.

Read More →

WHO urges countries to expand access to rapid molecular tests for the detection of TB and drug-resistant TB

WHO releases updated guidelines for TB diagnosis, recommending rapid molecular tests as initial tests for TB detection.

Read More →

WHO urges countries to enable access to fully-oral drug-resistant TB treatment regimens

WHO releases updated guidelines for the treatment of drug-resistant TB.

Read More →

Sustain, Adapt, Protect: A Call to Action on HIV, TB and COVID-19

Organizations are invited to sign on to a Call to Action on HIV, TB and COVID-19 developed by Frontline AIDS, ARASA, Global Coalition of TB Activists and TBpeople, alongside community organizations.

Read More →

Page 1 of 105 · Total posts: 10

1 2 Last→